Voyager Therapeutics, Inc. Quarterly Operating Income (Loss) in USD from Q1 2014 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Voyager Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2014 to Q2 2024.
  • Voyager Therapeutics, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$15M, a 40.9% increase year-over-year.
  • Voyager Therapeutics, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$6.65M, a 108% decline year-over-year.
  • Voyager Therapeutics, Inc. annual Operating Income (Loss) for 2023 was $122M.
  • Voyager Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$50.8M, a 30.9% increase from 2021.
  • Voyager Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$73.6M, a 369% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$6.65M -$15M +$10.4M +40.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 -$17.1M -$16.2M -$139M -113% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $122M $54.1M +$78.6M Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 $43.4M -$29.5M -$43.9M -304% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-06
Q2 2023 $87.3M -$25.4M -$6.06M -31.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $93.4M $123M +$144M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 -$50.8M -$24.6M -$30.3M -531% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 -$20.6M $14.4M +$39.6M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 -$60.2M -$19.4M +$9.22M +32.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 -$69.4M -$21.4M +$4.24M +16.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 -$73.6M $5.7M +$29.4M Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 -$103M -$25.1M -$110M -130% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $6.62M -$28.6M -$19.6M -218% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $26.2M -$25.6M -$1.16M -4.73% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $27.4M -$23.7M -$9.96M -72.3% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-07
Q3 2020 $37.3M $84.5M +$102M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 -$65M -$8.98M -$18.2M -198% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 -$46.8M -$24.4M +$4.86M +16.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 -$51.7M -$13.8M +$9.39M +40.6% Oct 1, 2019 Dec 31, 2019 10-K 2020-03-03
Q3 2019 -$61.1M -$17.8M +$3.34M +15.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$64.4M $9.19M +$34.9M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$99.3M -$29.3M -$8.2M -38.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 -$91.1M -$23.2M -$10.8M -87.6% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-03
Q3 2018 -$80.3M -$21.1M +$2.21M +9.45% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-03
Q2 2018 -$82.5M -$25.7M -$7.06M -37.9% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-03
Q1 2018 -$75.4M -$21.1M -$3.57M -20.4% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-03
Q4 2017 -$71.9M -$12.3M +$1.5M +10.8% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-26
Q3 2017 -$73.4M -$23.4M -$13M -125% Jul 1, 2017 Sep 30, 2017 10-K 2019-02-26
Q2 2017 -$60.4M -$18.6M -$9.02M -93.8% Apr 1, 2017 Jun 30, 2017 10-K 2019-02-26
Q1 2017 -$51.4M -$17.5M -$10.1M -135% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-26
Q4 2016 -$41.3M -$13.8M -$6.4M -86.1% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-14
Q3 2016 -$34.9M -$10.4M -$6.35M -158% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-14
Q2 2016 -$28.5M -$9.62M -$5.65M -142% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-14
Q1 2016 -$22.9M -$7.47M -$2.64M -54.7% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-14
Q4 2015 -$20.3M -$7.44M -$2.94M -65.5% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-15
Q3 2015 -$17.3M -$4.02M -$363K -9.93% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-15
Q2 2015 -$16.9M -$3.97M -$737K -22.8% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-15
Q1 2015 -$16.2M -$4.83M -$1.84M -61.7% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-15
Q4 2014 -$14.4M -$4.5M Oct 1, 2014 Dec 31, 2014 10-K 2016-03-17
Q3 2014 -$3.66M Jul 1, 2014 Sep 30, 2014 10-K 2016-03-17
Q2 2014 -$3.23M Apr 1, 2014 Jun 30, 2014 10-K 2016-03-17
Q1 2014 -$2.99M Jan 1, 2014 Mar 31, 2014 10-K 2016-03-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.